Mercaptamine bitartrate controlled-release - Chiesi Farmaceutici/Horizon Therapeutics
At a glance
- Drug Originator University of California, San Diego
- Drug Licenced by Chiesi Farmaceutici; Horizon Therapeutics plc
- Drug Class Mercaptoethylamines; Small molecules; Sulfhydryl compounds
- Mechanism of Action Metabolism-modulators
- USA Patent Applicants HORIZON
- USA Patents 21
- NDAs 2
- International Patents 62
- Patent Applications 15
Table of Contents
Disclaimer